A single-oral dose of ALB showed poor efficacy against both levels of infection intensity (low infection intensity: ERR: 64.4% [95% CI: -15.8; 96.3]; WRR: 39.0% [95% CI: 2.4; 69.1], high infection intensity: ERR: 59.0% [95% CI: -47.0; 83.4]; WRR: 23.2% [95% CI: -7.8; 49.7]). The gene discussed is ALB; the disease is infection.